Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.29M Buy
64,859
+11,380
+21% +$744K 0.03% 373
2026
Q1
$2.45M Buy
53,479
+6,256
+13% +$361K 0.02% 528
2025
Q4
$3.51M Buy
47,223
+2,262
+5% +$163K 0.03% 412
2025
Q3
$3.29M Buy
44,961
+16,516
+58% +$1.26M 0.03% 423
2025
Q2
$1.97M Buy
28,445
+15,297
+116% +$793K 0.02% 539
2025
Q1
$594K Buy
13,148
+692
+6% +$41K 0.01% 880
2024
Q4
$759K Buy
12,456
+3,216
+35% +$179K 0.01% 821
2024
Q3
$377K Buy
9,240
+697
+8% +$23.1K ﹤0.01% 1020
2024
Q2
$258K Sell
8,543
-390
-4% -$12.5K ﹤0.01% 1093
2024
Q1
$333K Buy
8,933
+745
+9% +$29.7K ﹤0.01% 1046
2023
Q4
$402K Buy
+8,188
New +$237K ﹤0.01% 998

Other funds holding AFRM

Xponance's AFRM Position: Q2 2026 in Review

Xponance increased its Affirm (AFRM) stake by 21% in Q2 2026, buying an estimated $744K and bringing the position to 64,859 shares worth $5.29M. The position accounts for 0.03% of the portfolio, ranked #373.

Xponance first reported a position in AFRM in Q4 2023 and has held it in 11 quarters since. 659 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Xponance held 64,859 shares of Affirm worth $5.29M as of Q2 2026.
  • Xponance bought 11,380 Affirm shares in Q2 2026, an estimated $744K.
  • Affirm made up 0.03% of Xponance's portfolio in Q2 2026, its #373 holding.
  • Xponance first reported a position in Affirm in Q4 2023 and has held it in 11 quarters since.
  • 659 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.